New digital aid could help survivors of sexual assault make clearer choices about HIV prevention

NCT ID NCT06139354

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This pilot study tests a digital decision aid designed for people who have experienced sexual assault and are considering HIV post-exposure prophylaxis (PEP). The tool helps patients and providers weigh risk, effectiveness, side effects, and personal priorities together. Researchers will measure whether the aid reduces decisional conflict and improves understanding of HIV PEP options.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
decision aid
What this could lead to
If effective, this decision aid could help sexual assault survivors make more informed, less conflicted choices about HIV prevention medication.
What could go wrong
This is a very small pilot study (18 people) testing only feasibility and decision conflict, not actual HIV prevention outcomes. Results may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • District of Columbia Forensic Nurse Examiners

    Washington D.C., District of Columbia, 20002, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.